Search Results 411-420 of 16866 for Cyproterone acetate
About this study. This is a multicenter, open-label, Phase 1, dose escalation trial to evaluate the safety, tolerability, and recommended Phase 2 dose ...
Learn how treatments and lifestyle changes might help reduce kidney damage from this disease.
Mayo Clinic doctors and scientists are leaders in prostate cancer research. Areas of focus include innovating diagnostic techniques, discovering and perfecting ...
Andress B, Miller SA, Maus AD, Kemp JV, Bornhorst JA, Grebe SK, Algeciras-Schimnich A. Undetectable Serum Thyroglobulin in Patients With Differentiated ...
Acalabrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as obinutuzumab, may ...
This phase 1 first-in-human study evaluates safety and tolerability of SBP-101 in subjects with previously treated pancreatic ductal adenocarcinoma and will ...
Learn about detection, diagnostic approaches, treatment options and advances for prostate cancer, including robotic prostatectomy and current research.
This phase III clinical trial is studying how well combination chemotherapy and surgery work in treating young patients with Bilateral Wilms tumor and children ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.